Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses

Laith J Abu-Raddad, Hiam Chemaitelly, Hadi M Yassine, Fatiha M Benslimane, Hebah A Al Khatib, Patrick Tang, Joel A Malek, Peter Coyle, Houssein H Ayoub, Zaina Al Kanaani, Einas Al Kuwari, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F Abdul Rahim, Gheyath K Nasrallah, Mohamed Ghaith Al Kuwari, Hamad Eid Al Romaihi, Mohamed H Al-ThaniAbdullatif Al Khal, Adeel A Butt, Roberto Bertollini

Research output: Contribution to journalArticlepeer-review

117 Downloads (Pure)
Original languageEnglish
JournalJournal of Travel Medicine
Early online date28 May 2021
DOIs
Publication statusEarly online date - 28 May 2021

Keywords

  • SARS-CoV-2
  • case–control
  • epidemiology
  • infection
  • one dose
  • vaccine
  • variant

Cite this